Pfizer Inc (PFE)
25.59
+0.46
(+1.83%)
USD |
NYSE |
Nov 22, 14:13
Pfizer Stock Buybacks (Quarterly)
Stock Buybacks (Quarterly) Chart
Historical Stock Buybacks (Quarterly) Data
| Date | Value |
|---|---|
| December 31, 2022 | 0.00 |
| September 30, 2022 | 0.00 |
| June 30, 2022 | 0.00 |
| March 31, 2022 | 2.00B |
| December 31, 2021 | 0.00 |
| September 30, 2021 | 0.00 |
| June 30, 2021 | 0.00 |
| March 31, 2021 | 0.00 |
| December 31, 2020 | |
| September 30, 2020 | |
| June 30, 2020 | |
| March 31, 2020 | |
| December 31, 2019 | 0.00 |
| September 30, 2019 | 0.00 |
| June 30, 2019 | 0.00 |
| March 31, 2019 | 8.865B |
| December 31, 2018 | 5.03B |
| September 30, 2018 | 1.105B |
| June 30, 2018 | 0.00 |
| March 31, 2018 | 6.063B |
| December 31, 2017 | 0.00 |
| September 30, 2017 | 0.00 |
| June 30, 2017 | 0.00 |
| March 31, 2017 | 5.00B |
| December 31, 2016 | 0.00 |
| Date | Value |
|---|---|
| September 30, 2016 | 0.00 |
| June 30, 2016 | 0.00 |
| March 31, 2016 | 5.00B |
| December 31, 2015 | 0.00 |
| September 30, 2015 | 160.00M |
| June 30, 2015 | 0.00 |
| March 31, 2015 | 6.00B |
| December 31, 2014 | 1.199B |
| September 30, 2014 | 1.281B |
| June 30, 2014 | 1.323B |
| March 31, 2014 | 1.197B |
| December 31, 2013 | 4.647B |
| September 30, 2013 | 3.754B |
| June 30, 2013 | 3.263B |
| March 31, 2013 | 4.626B |
| December 31, 2012 | 3.394B |
| September 30, 2012 | 1.835B |
| June 30, 2012 | 1.34B |
| March 31, 2012 | 1.659B |
| December 31, 2011 | 3.211B |
| September 30, 2011 | 2.11B |
| June 30, 2011 | 2.249B |
| March 31, 2011 | 1.43B |
| December 31, 2010 | 0.00 |
| September 30, 2010 | 500.00M |
Stock Buyback Definition
Stock buybacks are when companies buy back their own stock, removing it from the marketplace. Stock buybacks increase the value of the remaining shares because there is now less common stock outstanding and company earnings are split among fewer shares.
Stock Buybacks (Quarterly) Range, Past 5 Years
--
Minimum
Dec 2019
2.00B
Maximum
Mar 2022
222.22M
Average
--
Median
Dec 2019
Stock Buybacks (Quarterly) Benchmarks
| Amgen Inc | -- |
| Johnson & Johnson | 539.00M |
| Eli Lilly and Co | 446.10M |
| Merck & Co Inc | 444.00M |
| Moderna Inc | -8.00M |